According to a new report Europe Genetic Testing Market, published by KBV research, the Europe Genetic Testing Market would witness market growth of 10.8% CAGR during the forecast period (2019-2025).
The Germany market dominated the Europe Cytogenetic Testing Market by Country in 2018, growing at a CAGR of 10.4 % during the forecast period. The UK market is expected to witness a CAGR of 10.1% during (2019 - 2025). Additionally, The France market is expected to witness a CAGR of 12.6% during (2019 - 2025).
The Diagnostic Testing market dominated the Spain Genetic Testing Market by Type in 2018, growing at a CAGR of 11.3 % during the forecast period. The Prenatal and Newborn Testing market is expected to witness a CAGR of 11.3% during (2019 - 2025).
The Genetic Disease Diagnosis market dominated the Italy Genetic Testing Market by Application in 2018, growing at a CAGR of 10.4 % during the forecast period. The Cancer Diagnosis market is expected to witness a CAGR of 10.5% during (2019 - 2025).
Full Report:https://www.kbvresearch.com/europe-genetic-testing-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Myriad Genetics, Inc., Empire Genomics LLC, Bio-Rad Laboratories, Inc., Novartis AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Danaher Corporation, and Abbott Laboratories (Abbott Laboratories Molecular, Inc.).
By Type
By Technology
By Application
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
